KDx Diagnostics Inc. announces new distribution partnerships in Europe for the URO17® NON-INVASIVE Urine Test for Bladder Cancer

LOS GATOS, Calif., Nov. 9, 2023 /PRNewswire/ — KDx Diagnostics, a pioneering medical device company known for its innovative noninvasive urine test for bladder cancer, the URO17Ò test, is thrilled to announce strategic partnerships with leading distributors in Europe. These partnerships…